A. Fagiolini, A. Matone, C. Gaz, S. Panunzi, and A. De Gaetano, “Pharmacoeconomic comparison of ziprasidone with other atypical oral antipsychotic agents in schizophrenia”, FE, vol. 12, no. 1, pp. 29–40, Nov. 2011.